| Name | Title | Contact Details |
|---|
Kyros is committed to breaking down barriers, creating a community of support, and making a lasting impact on the lives of those affected by SUD. Through innovative training models, compassionate peer support, and a focus on human-centered solutions, Kyros strives to redefine recovery and provide hope for a healthier future. Founded in 2021 by Daniel Larson, after he encountered obstacles in his own journey with substance use disorder, Kyros` mission is to increase positive outcomes for the millions of Americans managing their own recovery or dedicating their lives to help others find support and wellbeing.
Since 1976, Salter Labs has positioned itself to approach both the hospital and home care markets with products reflecting both innovation and exceptional quality.
Omnibus Health is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
T1D Exchange, a nonprofit organization, is a dynamic, multi-purpose, real-world patient data platform designed to accelerate all aspects of drug and device development. T1D Exchange has established a unique model to speed better treatments, therapies and research for type 1 diabetes (T1D). The Exchange consists of an integrated Clinic Network of 65+ clinics across the U.S., a Clinic Registry of 26,000 well-characterized patients, a Biorepository, and Glu, an online community with mobile capabilities for people touched by type 1 diabetes. The T1D Exchange fosters faster and more fluid information transfer and sharing among diabetes patients, physicians, researchers, and pharma, medical device, education, and outreach organizations.
Bridgemedica is a Walpole, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.